ILD medications: nintendanib

ILD_NINTENDANIB

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L01XE31

138

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

125

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

125

diagram downward connector

Include endpoints None

125

diagram downward connector
ILD_NINTENDANIB

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 122 41 81
Unadjusted prevalence (%) 0.04 0.02 0.06
Mean age at first event (years) 70.56 70.25 70.72

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ILD_NINTENDANIB – ILD medications: nintendanib
GWS hits:

Survival analyses between endpoints

Plot

before ILD medications: nintendanib
after ILD medications: nintendanib

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after ILD medications: nintendanib